Suggested indications for HCT in rare PTCL
| . | Up-front consolidation . | Salvage consolidation . | Refractory . | ||
|---|---|---|---|---|---|
| . | autoHCT . | alloHCT . | autoHCT . | alloHCT . | alloHCT . |
| Extranodal NK/T-cell lymphoma45,46 | |||||
| Localized | - | - | + | + | + |
| Disseminated | + | - | + | + | + |
| Adult T-cell leukemia/lymphoma33 | |||||
| Chronic/smoldering | - | - | - | E | E |
| Acute/lymphoma | - | + | - | + | + |
| Enteropathy-associated T-cell lymphoma47,48 | + | - | E | E | E |
| Hepatosplenic T-cell lymphoma32 | E | + | - | + | + |
| . | Up-front consolidation . | Salvage consolidation . | Refractory . | ||
|---|---|---|---|---|---|
| . | autoHCT . | alloHCT . | autoHCT . | alloHCT . | alloHCT . |
| Extranodal NK/T-cell lymphoma45,46 | |||||
| Localized | - | - | + | + | + |
| Disseminated | + | - | + | + | + |
| Adult T-cell leukemia/lymphoma33 | |||||
| Chronic/smoldering | - | - | - | E | E |
| Acute/lymphoma | - | + | - | + | + |
| Enteropathy-associated T-cell lymphoma47,48 | + | - | E | E | E |
| Hepatosplenic T-cell lymphoma32 | E | + | - | + | + |
+ Recommendation based on evidence from registry studies and expert opinion.
E Recommendation based on expert opinion only.
- Not recommended.
Partly adapted from Kharfan-Dabaja et al.3